# LAMIVUDINE
> **ANDA204528** · Abbreviated New Drug Application (Generic) · Sponsor: NATCO · Approved 2016-03-04
## Drug
- **FDA Application Number:** ANDA204528
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LAMIVUDINE
- **Generic name:** Lamivudine
- **Active ingredients:** LAMIVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** NATCO
- **First approval:** 2016-03-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204528)
---
*MORVS · CC0 1.0*